[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2011063195A3 - Purification of modified cytokines - Google Patents

Purification of modified cytokines Download PDF

Info

Publication number
WO2011063195A3
WO2011063195A3 PCT/US2010/057364 US2010057364W WO2011063195A3 WO 2011063195 A3 WO2011063195 A3 WO 2011063195A3 US 2010057364 W US2010057364 W US 2010057364W WO 2011063195 A3 WO2011063195 A3 WO 2011063195A3
Authority
WO
WIPO (PCT)
Prior art keywords
purification
cytokines
modified cytokines
modified
methods
Prior art date
Application number
PCT/US2010/057364
Other languages
French (fr)
Other versions
WO2011063195A2 (en
Inventor
Darshan Koticha
Aniket B. Chaudhari
Kishore Jahagirdar
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2011063195A2 publication Critical patent/WO2011063195A2/en
Publication of WO2011063195A3 publication Critical patent/WO2011063195A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Methods for purifying modified cytokines. A process includes the use of a cation exchange chromatographic technique for the purification of a desired cytokine. The purified cytokines can be used in therapeutic compositions.
PCT/US2010/057364 2009-11-20 2010-11-19 Purification of modified cytokines WO2011063195A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2853/CHE/2009 2009-11-20
IN2853CH2009 2009-11-20

Publications (2)

Publication Number Publication Date
WO2011063195A2 WO2011063195A2 (en) 2011-05-26
WO2011063195A3 true WO2011063195A3 (en) 2011-11-24

Family

ID=44060355

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/057364 WO2011063195A2 (en) 2009-11-20 2010-11-19 Purification of modified cytokines

Country Status (1)

Country Link
WO (1) WO2011063195A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6030554B2 (en) 2010-07-29 2016-11-24 イレブン・バイオセラピユーテイクス・インコーポレイテツド Chimeric IL-1 receptor type 1 agonists and antagonists
US20140341843A1 (en) * 2011-07-29 2014-11-20 Eleven Biotherapeutics, Inc. Purified proteins
KR102236926B1 (en) 2013-03-13 2021-04-06 세센 바이오, 아이엔씨. Chimeric cytokine formulations for ocular delivery
EP3153522A1 (en) 2015-10-09 2017-04-12 Hetero Drugs Limited Process for the purification of erythropoietin and darbepoetin alfa
JP6906497B2 (en) * 2016-03-09 2021-07-21 Ｊｃｒファーマ株式会社 Method for producing mutant human erythropoietin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins
WO2003045996A1 (en) * 2001-11-28 2003-06-05 Sandoz Gmbh Chromatographic purification of recombinant human erythropoietin
EP1428878A1 (en) * 2002-12-13 2004-06-16 Siegfried Ltd. Process for the production and purification of erythropoietin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins
WO2003045996A1 (en) * 2001-11-28 2003-06-05 Sandoz Gmbh Chromatographic purification of recombinant human erythropoietin
EP1428878A1 (en) * 2002-12-13 2004-06-16 Siegfried Ltd. Process for the production and purification of erythropoietin

Also Published As

Publication number Publication date
WO2011063195A2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2010008823A3 (en) Purification of modified cytokines
HK1110306A1 (en) Crude glycerol-based product, process for its purification and its use in the manufacture of dichloropropanol
HK1178899A1 (en) Method for producing methyl-4,6-diamino-2-[1-(2-fluorobenzyl)-1h- pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-ylmethyl carbamate and its purification for use thereof as pharmaceutical substance 46--2-[1-(2-)-1h-[34-b]-3-]-5-
ZA200905167B (en) Process for the purification of water
EP2240573A4 (en) Methods using ion exchange and gel filtration chromatography for poxvirus purification
EP2133077A4 (en) Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
WO2013078170A8 (en) Purification of anti-c-met antibodies
GB201021935D0 (en) Hypoxia inducing factor (hif) stabilising glasses
ZA200610740B (en) Process for fine purification of 1-butenic streams
PL391380A1 (en) System and methods for purification of the transitional process gas
EP2130797A4 (en) Silica porous body, laminate and composition for optical use, and method for producing silica porous body
WO2011063195A3 (en) Purification of modified cytokines
GB0808908D0 (en) Purification process
EP1942078A4 (en) Method for purification of silica particles, purifier, and purified silica particles
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
EP2231574A4 (en) Process for the purification of fluromethyl 1,1,1,3,3,3,-hexafluoroisopropyl ether (sevoflurane)
PL1966110T3 (en) Purification process of iodixanol
PL2032514T3 (en) Process for preparing purified hydroquinone
GB201006553D0 (en) Fractionation purification apparatus
MY158910A (en) Surface modified silicic acid semi-gels
EP2502656A4 (en) Flocculating agent starting material using brown algae as starting material, flocculating agent using said starting material, preparation method for said flocculating agent, and purification method using said flocculating agent
WO2011156369A3 (en) Purification of modified cytokines
IL209580A (en) Halide-containing silicon, method for producing the same and use of the same in the purification of metallurgical silicon
EP2175033A4 (en) Large-scale purification method for 2-pyrone-4,6-dicarboxylic acid
GB0818228D0 (en) Purification process

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10832237

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 5228/CHENP/2012

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 10832237

Country of ref document: EP

Kind code of ref document: A2